Billionaires Holding KITE

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 43.7M
    Shares Outstanding

  • 2.53B
    Market Cap

News & Insights

ABOUT

KITE

Kite Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products. The company is developing a pipeline of engineered autologous cell therapy-based product candidates for the treatment of solid and hematological ...

Introducing The Vanguard REIT Index Fund

NEWS

Why Robo Advisors Are The Future

READ MORE